Antenatal Diagnosis of Placental Attachment Disorders (ADoPAD)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02442518|
Recruitment Status : Unknown
Verified December 2015 by NICOLA FRATELLI, Università degli Studi di Brescia.
Recruitment status was: Recruiting
First Posted : May 13, 2015
Last Update Posted : December 15, 2015
The accuracy of sonographic prenatal detection of invasive placentation is unclear. The objective of this prospective, multicenter, observational study is to assess the performance of ultrasound for prenatal identification of invasive placentation in women with placenta previa.
This study involves more than 25 hospitals in Italy.
|Condition or disease||Intervention/treatment|
|Placenta Accreta Placenta Previa||Procedure: antenatal ultrasound|
Show Detailed Description
|Study Type :||Observational|
|Estimated Enrollment :||2254 participants|
|Official Title:||Antenatal Diagnosis of Placental Attachment Disorders|
|Study Start Date :||February 2015|
|Estimated Primary Completion Date :||March 2018|
|Estimated Study Completion Date :||December 2018|
women with placenta praevia
women with placenta previa diagnosed at antenatal ultrasound in the third trimester of pregnancy (lower placental edge within 20 mm from the internal os above 26 week's gestation)
Procedure: antenatal ultrasound
Transabdominal and Transvaginal ultrasound examinations were performed in the third trimester (with some fluid in the bladder so that the uterine bladder interface could be evaluated well).
- diagnostic accuracy of sonographic prenatal detection of invasive placentation [ Time Frame: clinical and histopathological assessment of placental invasion at delivery ]
- maximum degree of placental invasion [ Time Frame: clinical and histopathological assessment of placental invasion at delivery ]
Biospecimen Retention: Samples Without DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02442518
|Contact: NICOLA FRATELLI, MDfirstname.lastname@example.org|
|Contact: FEDERICO PREFUMO, Phdemail@example.com|
|Azienda Ospedaliera San Gerardo di Monza||Recruiting|
|Monza, MB, Italy|
|Contact: PATRIZIA VERGANI, MD firstname.lastname@example.org|
|Brescia University, Spedali Civili Di Brescia||Recruiting|
|Brescia, Italy, 25131|
|Contact: NICOLA FRATELLI, MD +390303995340 email@example.com|
|Contact: FEDERICO PREFUMO, Phd +390303995340 firstname.lastname@example.org|
|ARNAS CIVICO di Cristina Benefratelli||Recruiting|
|Contact: GIUSEPPE CALI', MD email@example.com|
|Principal Investigator:||NICOLA FRATELLI, MD||BRESCIA UNIVERSITY, SPEDALI CIVILI DI BRESCIA|
|Principal Investigator:||GIUSEPPE CALI, MD||ARNAS Civico di Cristina Benefratelli|